Follow the people · Insider
Alexander Azoy
Alexander Azoy files insider transactions with the SEC as a chief accounting officer of Arcus Biosciences (RCUS). We hold 2 disclosed purchases and sales filed since 3 April 2019, 1 of them in the last 90 days.
- Files forRCUS
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure24 August 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 3 July 2023 — 21 August 2026Chief Accounting Officer · Arcus Biosciences (RCUS)29 Form 4 lines · source: SEC Form 4
- Filed 13 September 2020 — 13 September 2020Officer · Unity Biotechnology (UBX)1 Form 4 line · source: SEC Form 4
- Filed 1 April 2019 — 2 October 2019Chief Financial Officer · Sienna Biopharmaceuticals (SNNA)15 Form 4 lines · source: SEC Form 4
Everything they disclosed
45 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 2,827 shares of Arcus BiosciencesSEC Form 424 August 2026Common Stock · traded 21 August 2026 · filed 24 August 2026
- ▼ sold on the open market 2,827 shares of Arcus BiosciencesSEC Form 424 August 2026Common Stock · traded 21 August 2026 · filed 24 August 2026
- exercised options over 2,827 shares of Arcus Biosciences (a derivative holding)SEC Form 424 August 2026Stock Option (right to buy) · traded 21 August 2026 · filed 24 August 2026
- ▼ sold on the open market 2,562 shares of Arcus BiosciencesSEC Form 41 June 2026Common Stock · traded 1 June 2026 · filed 1 June 2026
- was granted 21,050 shares of Arcus BiosciencesSEC Form 426 January 2026Common Stock · traded 23 January 2026 · filed 26 January 2026
- was granted 14,050 shares of Arcus Biosciences (a derivative holding)SEC Form 426 January 2026Stock Option (right to buy) · traded 23 January 2026 · filed 26 January 2026
- was granted 14,050 shares of Arcus Biosciences (a derivative holding)SEC Form 426 January 2026Stock Option (right to buy) · traded 23 January 2026 · filed 26 January 2026
- was granted 21,050 shares of Arcus BiosciencesSEC Form 426 January 2026Common Stock · traded 23 January 2026 · filed 26 January 2026
- ▼ sold on the open market 2,376 shares of Arcus BiosciencesSEC Form 418 December 2025Common Stock · traded 16 December 2025 · filed 18 December 2025
- ▼ sold on the open market 2,113 shares of Arcus BiosciencesSEC Form 418 December 2025Common Stock · traded 17 December 2025 · filed 18 December 2025
- ▼ sold on the open market 4,343 shares of Arcus BiosciencesSEC Form 418 December 2025Common Stock · traded 18 December 2025 · filed 18 December 2025
- exercised options over 1,900 shares of Arcus Biosciences (a derivative holding)SEC Form 41 December 2025Stock Option (right to buy) · traded 26 November 2025 · filed 1 December 2025
- exercised options over 1,900 shares of Arcus BiosciencesSEC Form 41 December 2025Common Stock · traded 26 November 2025 · filed 1 December 2025
- ▼ sold on the open market 1,900 shares of Arcus BiosciencesSEC Form 41 December 2025Common Stock · traded 26 November 2025 · filed 1 December 2025
- ▼ sold on the open market 2,831 shares of Arcus BiosciencesSEC Form 430 September 2025Common Stock · traded 29 September 2025 · filed 30 September 2025
- ▼ sold on the open market 1,579 shares of Arcus BiosciencesSEC Form 45 September 2025Common Stock · traded 5 September 2025 · filed 5 September 2025
- was granted 11,400 shares of Arcus Biosciences (a derivative holding)SEC Form 427 January 2025Stock Option (right to buy) · traded 23 January 2025 · filed 27 January 2025
- was granted 17,100 shares of Arcus BiosciencesSEC Form 427 January 2025Common Stock · traded 23 January 2025 · filed 27 January 2025
- returned to the issuer 3,007 shares of Arcus BiosciencesSEC Form 420 December 2024Common Stock · traded 19 December 2024 · filed 20 December 2024
- had shares withheld for tax on 2,969 shares of Arcus BiosciencesSEC Form 417 December 2024Common Stock · traded 15 December 2024 · filed 17 December 2024
- ▼ sold on the open market 201 shares of Arcus BiosciencesSEC Form 44 December 2024Common Stock · traded 2 December 2024 · filed 4 December 2024
- ▼ sold on the open market 1,357 shares of Arcus BiosciencesSEC Form 415 August 2024Common Stock · traded 13 August 2024 · filed 15 August 2024
- was granted 5,900 shares of Arcus Biosciences (a derivative holding)SEC Form 425 January 2024Stock Option (right to buy) · traded 23 January 2024 · filed 25 January 2024
- was granted 8,850 shares of Arcus BiosciencesSEC Form 425 January 2024Common Stock · traded 23 January 2024 · filed 25 January 2024
- returned to the issuer 68 shares of Arcus BiosciencesSEC Form 422 December 2023Common Stock · traded 20 December 2023 · filed 22 December 2023
- returned to the issuer 647 shares of Arcus BiosciencesSEC Form 420 December 2023Common Stock · traded 18 December 2023 · filed 20 December 2023
- returned to the issuer 661 shares of Arcus BiosciencesSEC Form 420 December 2023Common Stock · traded 19 December 2023 · filed 20 December 2023
- ▼ sold on the open market 282 shares of Arcus BiosciencesSEC Form 45 December 2023Common Stock · traded 1 December 2023 · filed 5 December 2023
- ▼ sold on the open market 1,018 shares of Arcus BiosciencesSEC Form 45 July 2023Common Stock · traded 3 July 2023 · filed 5 July 2023
- was granted 135,000 shares of Unity BiotechnologySEC Form 415 September 2020Common Stock, $0.0001 par value · traded 13 September 2020 · filed 15 September 2020
- had shares withheld for tax on 2,396 shares of Sienna BiopharmaceuticalsSEC Form 44 October 2019Common Stock · traded 2 October 2019 · filed 4 October 2019
- returned to the issuer 25,000 shares of Sienna Biopharmaceuticals (a derivative holding)SEC Form 48 August 2019Stock Options (Right to buy) · traded 6 August 2019 · filed 8 August 2019
- returned to the issuer 5,600 shares of Sienna Biopharmaceuticals (a derivative holding)SEC Form 48 August 2019Stock Options (Right to buy) · traded 6 August 2019 · filed 8 August 2019
- returned to the issuer 20,000 shares of Sienna Biopharmaceuticals (a derivative holding)SEC Form 48 August 2019Stock Options (Right to buy) · traded 6 August 2019 · filed 8 August 2019
- returned to the issuer 8,750 shares of Sienna Biopharmaceuticals (a derivative holding)SEC Form 48 August 2019Stock Options (Right to buy) · traded 6 August 2019 · filed 8 August 2019
- returned to the issuer 8,750 shares of Sienna Biopharmaceuticals (a derivative holding)SEC Form 48 August 2019Stock Options (Right to buy) · traded 6 August 2019 · filed 8 August 2019
- was granted 25,000 shares of Sienna Biopharmaceuticals (a derivative holding)SEC Form 48 August 2019Stock Options (Right to buy) · traded 6 August 2019 · filed 8 August 2019
- was granted 5,600 shares of Sienna Biopharmaceuticals (a derivative holding)SEC Form 48 August 2019Stock Options (Right to buy) · traded 6 August 2019 · filed 8 August 2019
- was granted 8,750 shares of Sienna Biopharmaceuticals (a derivative holding)SEC Form 48 August 2019Stock Options (Right to buy) · traded 6 August 2019 · filed 8 August 2019
- was granted 8,750 shares of Sienna Biopharmaceuticals (a derivative holding)SEC Form 48 August 2019Stock Options (Right to buy) · traded 6 August 2019 · filed 8 August 2019
- was granted 20,000 shares of Sienna Biopharmaceuticals (a derivative holding)SEC Form 48 August 2019Stock Options (Right to buy) · traded 6 August 2019 · filed 8 August 2019
- was granted 70,000 shares of Sienna BiopharmaceuticalsSEC Form 48 August 2019Common Stock · traded 6 August 2019 · filed 8 August 2019
- had shares withheld for tax on 1,552 shares of Sienna BiopharmaceuticalsSEC Form 43 July 2019Common Stock · traded 2 July 2019 · filed 3 July 2019
- was granted 20,000 shares of Sienna Biopharmaceuticals (a derivative holding)SEC Form 43 April 2019Stock Options (Right to buy) · traded 1 April 2019 · filed 3 April 2019
- was granted 20,000 shares of Sienna BiopharmaceuticalsSEC Form 43 April 2019Common Stock · traded 1 April 2019 · filed 3 April 2019
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.